SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year operating income growth rate
Latest
-24.38%
↑ 43% vs avg
Percentile
P30
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-42.65%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -24.38% |
| Q3 2025 | -30.28% |
| Q2 2025 | 9.65% |
| Q1 2025 | -7.63% |
| Q4 2024 | 11.50% |
| Q3 2024 | -10.86% |
| Q2 2024 | 10.44% |
| Q1 2024 | 39.65% |
| Q4 2023 | -254.57% |
| Q3 2023 | 17.81% |
| Q2 2023 | 12.50% |
| Q1 2023 | 5.83% |
| Q4 2022 | -0.67% |
| Q3 2022 | -19.32% |
| Q2 2022 | 2.45% |
| Q1 2022 | 8.67% |
| Q4 2021 | -84.05% |
| Q3 2021 | -38.91% |
| Q2 2021 | -452.92% |
| Q1 2021 | -90.52% |
| Q4 2020 | 0.00% |